Pretty evident the BDD OralogiK tablet for IBD is progressing well, or at least expectations don't seem to include any major hindrances, since they already have a time table as to the UC clinical trial - by end of year or shortly thereafter.

The K pill was already pretty well advanced when they had to shut it down for financial reasons so it could be well on the way to being completed already. Expect some major surprises/news to come out of the Kevetrin camp way before many people expect - just my WAG, and it is going to get the attention of big medicine in a dramatic way.

Also believe ABSSSI may get the attention of governmental bodies worldwide once Brilacidin starts showing major successes against OM and IBD so maybe that gets kickstarted w/ govt grants to get the P3 going. Outside chance on this but one never knows.